Programme Community Pharmacy Section

3 – 8 September 2009

Responsibility for Patient Outcomes - Are you ready? p

I S T A N B U L

T U R K E Y

Thursday 3 September 2009 – Morning and Afternoon FORUM FOR INNOVATORS IN PHARMACY PRACTICE Managing Change – Quality Work in Pharmacies

How to improve your professional and business practice and how to integrate services to your business models - Managing the process

Pre-satellite symposium, separate registration fee Accredited programme Introduction The Community Pharmacy Section has a long tradition for organising continuing education for

the professional leaders in community pharmacy. The theme of the educational programme 2007-2008 was Managing Change. This is a very important topic as the challenges for pharmacy practice are huge, and the profession has to go through intensive changing processes to be able to adapt to these challenges and to design the future. The theme Managing Change will continue in 2009 when we shall look at the outcomes of the service production and the integration of the new services into the business plans of pharmacies.

Learning objectives After the seminar the participants should be able to:

describe the known basic principles of quality management and quality systems

use the FIP- GPP document together with general quality documents for implementation of quality work on pharmacy level

understand the goals of the CPS project “Quality work in pharmacies”

produce the documentation needed for international benchmarking Chairpersons: Hanne Herborg, Pharmakon, Denmark

Charlie Benrimoj, University of Sydney, Australia Eeva Teräsalmi, FIP Community Pharmacy Section, Finland

Programme: Welcome and introduction Hanne Herborg, Pharmakon, Denmark

Introduction to Good Pharmacy Practice Eeva Teräsalmi, FIP Community Pharmacy Section, Finland

Quality and safety in health care

Speaker TBI

Workshop I based on the first two presentations Country cases

(Australia, Denmark, Finland, Netherlands, Switzerland, Thailand)

Workshop II Task 1: Identify needs in relation to international quality work in pharmacies Task 2: Develop international benchmarking indicators

Quality systems in Pharmacy Charlie Benrimoj, University of Sydney, Australia

Discussion Closure

Friday 4 September 2009 - Morning CURRENT TRENDS IN COMMUNITY PHARMACY IN TURKEY Organised in collaboration with the Turkish Pharmacists’ Association and IMS Health Would you like to know more about pharmacy practice in Turkey? In that case, we would like

to invite you to a programme consisting partly of a seminar with presentations by Turkish experts, partly of visits to pharmacies in Istanbul.

Separate registration

For logistic reasons, separate registration is required and is only possible in addition to a full Congress registration. Deadline for registration is 1 August 2009. As the programme has limited access, early registration is recommended. Registrations will be handled on a first come- first served basis.

Learning objectives After this programme the participants will be able to:

explain the Turkish pharmacy system

describe the Turkish pharmaceutical market

understand community pharmacy practice in a multicultural society Chair: Martine Chauvé, FIP Community Pharmacy Section, France

Co-Chair: Serif Boyaci, Turkish Pharmacists’ Association, Turkey Programme The Pharmacy System in Turkey

Speaker TBI Current trends in the pharmaceutical market in Turkey

Speaker TBI Pharmacy visits

Saturday 5 September 2009 - Morning Cultural and health beliefs behind the medicine use Symposium jointly organised with the Pharmacy Information Section and the

Military and Emergency Pharmacy Section Accredited programme Pharmacists are caring for more individuals of diverse age, gender, race, ethnicity, socio-

economic status, religion, sexual orientation, and health beliefs than in previous decades. Effective delivery of culturally and linguistically appropriate service in cross-cultural settings is identified as cultural competence. Culture is a dynamic process, with people moving in and out of various cultures throughout their lives. The failure to understand and respect individuals and their cultures could impede pharmaceutical care. This symposium addresses some of the aspects.

Learning objectives After participating in this symposium the participants should

Identify the cultural and personal factors affecting the medicine use and health

Explain how these beliefs should be taken into account in their practice and their own customer service

Chairs: Eugene Lutz, FIP Community Pharmacy Section, USA

Regis Vaillancourt, Children’s Hospital, Ontario, Canada Programme What do we know of beliefs affecting people’s perceptions of health and medicines?

Alexander Dodoo, Pharmacy Information Section, Ghana How to make partnerships with patients in reaching better adherence by improving cultural

competences among health professionals Anna Mygind, Faculty of Pharmaceutical Sciences, University of Copenhagen, Denmark

Pictographic Instructions for Medications — What has been learnt?

Regis Vaillancourt, Children’s Hospital, Ontario, Canada How to adapt to the multicultural and multilingual pharmacy environment

Lessons learnt and tools for pharmacists Hemant Patel, FIP Community Pharmacy Section, UK

Discussion

Saturday 5 September 2009 - Afternoon Sustainable flow of pharmaceuticals Symposium jointly organised with the Industrial Pharmacy Section A sustainable development is a development that "meets the needs of the present without

compromising the ability of future generations to meet their own needs" as it is defined in the United Nations 1987 Report of the World Commission on Environment and Development, also called the Brundtland Commission Report. Pharmaceuticals are important in a modern society. The use of medicines is growing, and we are urging researchers, the industry and the financing part of society to give us effective medicines for a better health in all parts of the world. How can we achieve this in a sustainable way? Sustainability needs a proactive view on the processes we are active in. Will researchers be able to design pharmaceuticals with low environmental impact? Can the industry find production procedures with minimal waste? Will Authorities weigh the sustainability of products when judging effectiveness and costs? What measures can we use in distribution chains? Which responsibility are pharmacists willing to take concerning adherence and the best use of medicines? How can we encourage patients to take better responsibility for adherence to their medication and to secure that unused medicines are returned to pharmacies or otherwise handled in a way that minimises the amount of substances affecting environment. And finally how can we minimise residual medicines, and how do we destroy those that were left over anyhow in a responsible way?

Target audience

Pharmacists working in community pharmacy, in hospital pharmacy or in the military Pharmacists in the pharmaceutical industry or in authorities. Students, young pharmacists and educators.

Learning objectives

At the conclusion of this session, participants will be able to:

see the global flow of pharmaceuticals as a chain where every link has its viable part

understand the challenge of the sustainable design of pharmaceuticals

discuss the driving forces for Industry, Authorities, Distributors

identify the work needed to minimise residual pharmaceuticals

understand the necessity for the ratio maximal medical benefit/minimal environmental influence to be as high as possible

Chairs: Astrid Kågedal, Apoteket AB, Sweden

Ulf Janzon, FIP Industrial Pharmacy Section, Sweden Programme Introduction: What do we mean by Sustainable Development?

Speaker TBI Pharmaceutical Green Chemistry

Peter Dunn, Pfizer, UK Responsibility for authorities and payers

Bettina Rechenberg, Umwelt Bundesamt, Germany

Prescribers and Patients assuming responsibility for the environment

Åke Wennmalm, Stockholm City Council, Sweden Bo Gunnarsson, Apoteket AB, Sweden

Summing up by the chair: This is of global interest

Ulf Janzon, FIP Industrial Pharmacy Section, Sweden

Saturday 5 September 2009 - Afternoon Educating patients about how to make use of web-based information sources Symposium jointly organised by the Pharmacy Information Section and the Community

Pharmacy Section Accredited programme The pharmacist-patient relationship is changing rapidly towards a more active partnership,

fostered by the increasing access to information about treatments and medicines and the consumerist trends in modern society. How can we describe the pharmacists position as gatekeeper at the end of the drug distribution chain if patients have more information sources and alternative modes for obtaining medications (internet) than ever? Are pharmacists ready to satisfy the needs of patients by integrating the web-based information in their provision of pharmaceutical care?

Learning objectives:

At the conclusion of this session, the participants should be able to: describe the use of web-based information on medicines and treatments by patients list what factors need to be addressed when providing pharmaceutical care using web-

based information sources discuss the impact of accountability for sharing information with patients and patient

outcomes give an opinion on how to achieve a better use of web-based patient drug information

Chairs: Christie Robinson, FIP Pharmacy Information Section, USA and TBI Programme Patients' preferred sources of web-based information - is the information reliable?

The proposals of the European Commission on information to patients Ulla Närhi, Finland

How to educate patients about the use of reliable web-based information sources

Christie Robinson, FIP Pharmacy Information Section, USA

Impact of web-based information on medicines and treatments on patient outcomes

Speaker TBI

The role of the pharmacist as the patient’s partner in searching web-based information

Cairo Toledano, FIP Young Pharmacists Group, Mexico

Discussion

Sunday 6 September 2009 - Morning FORUM FOR POLICY MAKERS: Trends in Community Pharmacy – debating the future of the

profession Joint symposium with YPG, IPSF, and Administrative Pharmacy Section

Accredited programme Format

Moderated session with short interventions from selected speakers invited by CPS and APS as well as young pharmacists and pharmacy students by YPG and IPSF – to present challenges and views of the different topics chosen. After the interventions on a topic, other member countries or individuals having an interest or expertise in the topic are invited to comment.

Learning objectives

At the conclusion of this session, the participants should be able to:

identify some of the global and regional trends that influence community pharmacy practice

understand and describe issues related to pharmacist reimbursement, ethical practice and expanding roles in primary health care

acknowledge the range of views of participants from different sectors and levels of the profession: Member organisations, community pharmacists, young pharmacists and pharmacy students

discuss how community pharmacists can be prepared for changes in pharmacy practice

discuss how community pharmacists can deal with and seize opportunities presented by changes in pharmacy practice

Community pharmacists are at present facing a number of challenges and opportunities. No matter where in the world community pharmacists are practicing, issues such as funding and reimbursement of cognitive services, ethical pharmacy practice and the extending role in primary health care are ineluctable. It is thus crucial to have an open debate within the profession, encompassing practicing pharmacists as well as the future professionals. Focus should be given to the recent changes and upcoming trends in community pharmacy practice and healthcare systems that impact on the profession globally.

Target audience

Policy makers in pharmacy practice, pharmacists working in community healthcare, pharmacists working in administrative pharmacy as well as young pharmacists and students.

Chair: Ema Paulino, FIP Community Pharmacy Section, Portugal

Co-Chair: Inka Puumalainen, FIP Administrative Pharmacy Section, Finland Programme Topic A – Economic models – Are pharmacists “good value for money”?

If resources are directed towards health services, these same resources cannot be used to provide other types of goods and services. As a result, choices need to be made by governments about which activities or services should be provided. Therefore, it is important to assess the cost effectiveness of pharmacists providing services. But what sort of funding model(s) should support the provision of services provided by pharmacists? This talk will focus on recent changes in the remuneration of pharmacy services in different countries and how

these can be seized by practicing community pharmacists. Keynote speaker: Eugene Lutz, USA Responses: Michel Buchman, Switzerland Lindsay McClure, UK John Nguyen, Australia

Topic B – Business versus Care? - Ethical pharmacy practice

Weight loss programmes, advice on herbal medicines, supplements and vitamins are seen by some as a legitimate activity for pharmacists that contribute to the overall health and well-being of their customers. However, some consider that pharmacists use their pharmacies as vehicles to push weight loss schemes and non-evidence based therapies as a way to increase profits. Additionally, what should the pharmacist consider when making recommendations in what regards different brands of a certain product? The talk will address issues related to ethical practice and how (and if) it is possible to blend business and care. Keynote speaker: Betty Charr, Australia

Responses: Inka Puumalainen, Finland Halil Tekiner, Turkey Anca Pop, Romania

Topic C - Expanding roles for pharmacists in primary health care In the primary care setting, pharmacists can provide direct patient care; face-to-face counselling and education to their patients; prescribing advice to other providers; advise on cost-effective drug therapy and options for treatments; vaccination; tests for STDs and minor ailments; and chronic disease therapy management. This talk will examine the role expansion of community pharmacy and describe pharmacy's thrust towards an extended and more meaningful role, making a clear distinction between the role expansion concerning the granting of additional powers to prescribe medications, and that of a wider range of activities. Keynote speaker: Ross Tsuyuki, Canada Responses: Natasa Nikolic, Serbia Sónia Faria, Portugal Tuğrul Mert Serim, Turkey

Sunday 6 September 2009 - Afternoon 14:00 Professionalism at the pharmacy - How do we ensure that, independently of ownership?

Horizon scanning in the developing world Chair: Martine Chauvé, FIP Community Pharmacy Section, France Professionalism at the pharmacy - How do we ensure that, independently of ownership?

Horizon scanning in the developing world Speaker TBI

16:00 Steering committee meeting (open to delegates and observers)

Sunday 6 September 2009 Sharing information with patients to enhance treatment outcomes Joint symposium with Pharmacy Information Section

Accredited programme Pharmacists are at the end of the drug distribution chain. But the question remains whether

pharmacists are changing their practices in order to be accountable for patient outcomes. If that is the way forward more emphasis needs to be given to opportunities for sharing information with patients, on their concerns, expectations, and beliefs together with information on experiences regarding side effects and treatment outcomes. If pharmacists are no longer focussed on distribution models only, but would like to be more involved in care practice sites, what will be the change in information exchange with patients and physicians?

Learning objectives

At the conclusion of this session, the participants should be able to: describe the models for sharing information with patients on their treatments and

medicine use list what factors need to be addressed when sharing information to enhance

treatment outcomes discuss the impact of accountability for sharing information with patients and

physicians in integrated care models learn from examples where pharmacists and patients have had experiences to share

information to improve patient outcomes

Chairs: Lindsay McClure, FIP Pharmacy Information Section, UK and TBI

Programme Overview of evidence that show a relationship between sharing information and better

treatment outcomes Theo Raynor, University of Leeds, UK

A patients’ perspective: why sharing of information on medicine use is important for patients?

Albert van der Zeijden, The Netherlands Accountability issues when sharing information with patients

Speaker TBI

New models of sharing information with patients for improving pharmacist-patient relationships Han de Gier, The Netherlands

Discussion

Monday 7 September 2009 – Morning and afternoon THE PRACTITIONERS’ DAY Posters and short oral communications organised in 4 different topics (2 in the morning and 2

in the afternoon) Accredited programme Introduction

Congress participants are invited to submit abstracts for short oral presentation within the four topics specified below. Among the abstracts received, a number will be selected for oral presentation. All accepted abstracts will be presented as posters.

Format

There will be four fora, two running in parallel in the morning, and two in parallel in the afternoon. Each forum will be chaired by two facilitators whose task will be to encourage participants to interactive exchange of views.

Target audience

Pharmacists working in community pharmacy, policy makers in pharmacy practice, young pharmacists, students and educators.

Learning objectives

This session aims to:

provide a forum in which practitioners and other interested partners can present their experiences as well as expand and share their knowledge of topics relevant to community pharmacy practice

promote networking between community pharmacists and other partners interested in community pharmacy practice.

Poster Session

The Community Pharmacy Section invites for contributions to the Poster Session. We welcome Congress participants’ abstracts for poster presentation not only on the topics mentioned hereafter, but also on other topics of relevance to community pharmacy. A jury appointed by the Executive Committee of the Community Pharmacy Section will select the best poster(s) for the CPS Poster Award.

Morning Quality assurance in community pharmacy Chairpersons:

Eugene Lutz, FIP Community Pharmacy Section, USA Patti Payne, FIP Community Pharmacy Section, Australia

Speakers to be identified based on submitted abstracts New pharmacy services in e-world Chairpersons:

Dominique Jordan, FIP Community Pharmacy Section, Switzerland Samira Goussous, FIP Community Pharmacy Section, Jordan

Speakers to be identified based on submitted abstracts Afternoon The role of the pharmacist in Public health Chairpersons:

Warren Meek, FIP Community Pharmacy Section, Canada Hemant Patel, FIP Community Pharmacy Section, UK

Speakers to be identified based on submitted abstracts Compounding in community pharmacy Chairpersons:

Martine Chauvé, FIP Community Pharmacy Section, France Hélène Leblanc, Ordre National des Pharmaciens, France

Speakers to be identified based on submitted abstracts Tuesday 8 September 2009 – Morning and Afternoon Compounding seminar: an international overview Accredited programme If pharmaceutical compounding was originally the core activity of the pharmacist, it is today

often seen as a satellite practice. However, compounding medicines are crucial to adjust dosage to paediatric needs and answer excipient tolerance problems. In the current move towards personalised medicines, compounding medicines also find a new interest. In some developing countries, compounding medicines can sometimes supplement the chain of industrial medicines. An overview of the different practices and regulatory frameworks in the world will help us understand the challenges and opportunities for compounding medicines today and in the future.

Chair: Peter R. Ford, Canada Co-chair: TBI Learning objectives:

At the conclusion of this session, the participants should be able to: - present an overview of the evolution of pharmaceutical compounding practices all

around the world - define the involvement of pharmacists in compounding medicines - list solutions on issues related to compounding medicines - describe the benefits provided by compounding medicines to patients and the interest

of compounding medicines in the future - discuss the challenges and opportunities for compounding medicines in the future

Target audience The session is targeted at a wide range of pharmacy professionals such as pharmacy practice professionals, representatives of pharmacists’ organisations, pharmacy students and recent graduates

Programme Introduction: Setting the scene

Speaker TBA Overview of practices all over the world Turkey: Alper Sahin Switzerland: Speaker TBI Venezuela: Arianna Cirottola, Facultad de Farmacia de la Universidad Central de Venezuela Africa: Dr. Gaëtan Bahiol, Cameroun Asia: Speaker TBI Conclusion: the future of compounding medicines

Peter R. Ford, Canada